stockrow
Friday 6 November 2026
Export ONMD’s income statement to Excel — free account
OneMedNet Corporation
ONMD Healthcare Health Information Services
OneMedNet Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.4 million, up 111.4% from fiscal 2024.
- Revenue
- +88.4%
- EPS
- −157.1%
- Free cash flow
- +14.1%
- Total debt
- +75.3%
Quarter to June 2026, against a year earlier
5.14
0.97
+23.26%
Follow ONMD
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 4 | 4 | — |
+8 more TTM periods Free account |
| 231.20% | 32.50% | 29.62% | 22.34% | ||
| (459.66%) | (206.98%) | (95.30%) | (69.02%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
253.00% | 87.11% | 104.75% | 58.13% | |
Average Days of Receivables |
166.57 | 193.02 | 132.95 | 429.15 | |
Free Cash Flow per Share |
(1.19) | (1.30) | (1.69) | (1.49) | |
Free Cash Flow |
(6.89) | (7.20) | (7.52) | (7.83) | |
Capital Expenditures |
(0.02) | (0.01) | (0.01) | (0.04) | |
| Other line items | |||||
Cash ROIC |
280.32% | 244.68% | 835.11% | 279.41% | |
Accounts Receivable Turnover |
3.17 | 2.79 | 3.84 | 1.53 | |
Accounts Payable Turnover |
0.56 | 0.37 | 0.39 | 0.24 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
520.10 | 727.60 | 685.31 | 1,162.38 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
97.59% | 112.14% | 111.48% | 281.62% | |
Selling, General and Administrative Expense of Revenue |
535.40% | 596.21% | 562.84% | 1,440.20% | |
Share Based Compensation of Revenue |
173.26% | 171.09% | 149.52% | 147.07% | |
Interest Coverage |
(308.88) | (217.28) | (144.28) | (106.16) | |
Operating CF/Net income |
0.81 | 2.15 | 2.68 | 3.83 | |
Depreciation/Fixed assets |
0.69 | 1.36 | 1.16 | 1.37 | |
Capex/Depreciation |
(0.46) | (0.16) | (0.20) | (0.52) | |
Revenue per Share |
0.25 | 0.24 | 0.31 | 0.09 | |
Operating CF per Share |
(1.19) | (1.30) | (1.68) | (1.48) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.09 |
Columns are period end dates · fundamentals updated 2 Nov 2026